
Genapsys Stock
GenapSys develops DNA sequencing technologies and systems for applied genomic testing and medical sequencing.
About Genapsys Stock
Funding History
May 2012 | $0 |
---|---|
March 2013 | $8.5M |
November 2013 | $37.0M |
Management
Head of Talent & Happiness
Diana Kofman
Director of Nanofabrication
Kosar Parizi
Director of Business Development
Avaleigh Milne
Senior Director & Head of Europe
Leila Zegna
Director of Sequencing
Xavier Gomes
Leads Strategic Initiatives
Howard Goldstein
VP of Product Development
Subra Sankar
VP Engineering
Hamid Rategh
Director of Product & Test Engineering
Ashok Ramachandran
Director of Chemistry
Aldrich Lau
Press
Other Companies

Atreca
Atreca develops a technology to identify the set of antibodies produced during an immune response, without prior knowledge of an antigen.

BRAIN
BRAIN provides biodiversity-based solutions for applications in the chemical, pharmaceutical, cosmetics and food industries.
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Genapsys or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase